Christopher Thomas Giordano - CEO, Director at TENAX THERAPEUTICS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Issuer Symbol
TENX on Nasdaq
All Insider Reports
All Insider Reports

Christopher Thomas Giordano - trading volume in the past year for TENAX THERAPEUTICS, INC.

Holdings reported by Christopher Thomas Giordano for TENAX THERAPEUTICS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 450,000 $4,050,000 $9.00 09 Jan 2026 Direct Common Stock 450,000
Common Stock 2,605 $23,445 $9.00 09 Jan 2026 Direct

Transactions reported by Christopher Thomas Giordano for TENAX THERAPEUTICS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.